What is RPTX's current stock price?

As of now, RPTX is trading at $0.90, with a daily change of -3.23%.

What are RPTX stock strengths?

RPTX strengths include Earnings are forecast to grow, Upgraded on attractively valued, .

What are the risks associated with RPTX stock?

RPTX Key risk is its Low Risk Level, .

What is RPTX next earnings date?

RPTX next earnings report is scheduled for --.

What is RPTX's current stock rating?

RPTX's current stock rating is Hold.

Should I buy RPTX stock right now?

Based on the current rating of Hold, it is advisable to consider Hold as your next step with RPTX stock.

Is RPTX a Strong Buy right now?

RPTX's current stock rating is Hold, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for RPTX?

A 'Strong Buy' rating for RPTX indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for RPTX?

A 'Strong Sell' rating for RPTX suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence RPTX's stock rating?

RPTX's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Repare Therapeutics (RPTX) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Ideas

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

RPTX

Repare Therapeutics

$0.90

-$0.03 | -3.23%

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

Open

$ 0.91

MKT CAP

$ 38.26M

High

$ 0.97

VOL

$ 180.60K

Low

$ 0.89

AVG VOL

$ 236.68K

Chart

1.17

1.28

3.28

3.2

1year

6month

3month

1month

RPTX Latest Headlines +

NRXBF Enters Crucial Stage in Good Shape. By NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries while also conducting preclinical tests for other conditions that ExoPTEN may be able to treat. On that latter point the company late last year announced some preclinical test results that have the potential to benefit thousands of patients and increase the value of NRXBF to investors. More recently however the company annou

Thu Apr 10, 2025

Activity

ADF GROUP INC. ANNOUNCES THE RESULTS FOR THE FISCAL YEAR ENDED JANUARY 31 2025. HIGHLIGHTSRevenues of Net income of Cash flow from operations of The Corporation'.s order backlog (1) totalled ADF GROUP INC. (".ADF". or the ".Corporation".) (TSX: DRX) recorded revenues of Gross margin as a percentage of revenues (1) went from 22.0% for the fiscal year ended Adjusted earning before interest taxes depreciation and amortization (2) (adjusted EBITDA) for the fiscal year ended Januar

Thu Apr 10, 2025

Activity

Potential

IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results. Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth 42% decrease in Operating Expenses and Company". or ".IMC".) (NASDAQ:) (CSE:) an international medical cannabis company is pleased to announce its financial results for the fourth quarter and year ended The Company'.s audited consolidated financial statements for the fiscal years ended Q4 MD&.A".) together with it

Mon Mar 31, 2025

Activity

Global Atomic Announces 2024 Results. ) (OTCQX:) (FRANKFURT: G12) announced today its operating and financial results for the year ended . Global Atomic President and CEO ".Until a financing commitment is signed the Company will manage its spending in the near term. By managing the current cash position we will have additional time to finalize terms with an option best suited to the Company and its shareholders without coming back to the equity market in the near term. We appreciate the p

Thu Mar 27, 2025

Activity

Potential

Rating

Explore our RPTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored RPTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our RPTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

Ideas

Earnings

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

RPTX

Repare Therapeutics

$0.90

-$0.03 | -3.23%

Chart

1.17

1.28

3.28

3.2

1year

6month

3month

1month

Discover RPTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of RPTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our RPTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

RPTX Stock trends

RPTX Stock performance

RPTX Stock analysis

RPTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

RPTX Stock Analysis for the Last 90 Days

RPTX Risk Level

RPTX Analysts Opinion

RPTX Street Consensus

RPTX Performance Sentiment

Technical Price Levels

RPTX Financial Health

Explore our RPTX Stock insights

Receive our RPTX Daily Alerts

RPTX Stock Analysis for the Last 90 Days

RPTX Street Consensus

Technical Price Levels

Discover RPTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of RPTX. We're here to help you make informed investment decisions today.

Receive our RPTX Daily Alerts